Benefits of Immunotherapy Match Those of Chemotherapy, New Mesothelioma Study Finds

A trial of immunotherapy drug pembrolizumab in patients with mesothelioma has had promising results. The trial shows that the benefits of the therapy equal those of standard chemotherapy, which can cause a lot of uncomfortable side effects. Researchers hope that the study will also shed light on why some patients respond better to immunotherapy than […]

Read More